Two Sigma Securities’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,500
Closed -$644K 3559
2024
Q1
$644K Buy
3,500
+700
+25% +$133K 0.01% 1400
2023
Q4
$503K Buy
2,800
+900
+47% +$140K ﹤0.01% 1550
2023
Q3
$302K Buy
1,900
+400
+27% +$65.4K ﹤0.01% 1954
2023
Q2
$212K Buy
+1,500
New +$241K ﹤0.01% 2168
2023
Q1
Sell
-1,300
Closed -$220K 3155
2022
Q4
$220K Buy
+1,300
New +$236K 0.01% 1856
2020
Q1
Sell
-5,400
Closed -$500K 2125
2019
Q4
$500K Buy
+5,400
New +$454K ﹤0.01% 1448

Other funds holding RGEN

Two Sigma Securities's RGEN Position: Q1 2026 in Review

Two Sigma Securities sold out of Repligen (RGEN) in Q1 2026, closing a stake of 5,226 shares — an estimated $856K sold.

Two Sigma Securities first reported a position in RGEN in Q4 2018 and held it in 12 quarters. The position peaked at $1.58M in Q3 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Two Sigma Securities reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 5,226 Repligen shares in Q1 2026, an estimated $856K.
  • Two Sigma Securities first reported a position in Repligen in Q4 2018 and held it in 12 quarters.
  • Two Sigma Securities's Repligen position peaked at $1.58M in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.